Augmentation of soft tissue defect in face, trunk and extremity with adipose-derived regenerative cell enriched lipotransfer. - Augmentation of soft tissue defect with adipose-derived regenerative cell enriched lipotransfer.

agoya University Hospital0 个研究点目标入组 30 人开始时间: 2014年2月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•The exclusion criteria will be as follows; 1. Patients failed to receive informed consent. 2. Patients who is considered to live less than 1 year due to other complications. 3. Patients who has or has a history of malignant tumor in 5 years. Or patients who is evaluated to possess malignant tumor by other examinations. 4. Patients who possess severe inflectional disease or is positive for WR-a, HCV, HB, or HIV. 5. Patients with severe hepatic or renal disorders. 6. Patients with leucopenia, thrombocytopenia, or other severe hematopoietic disorders or severe anemia. 7. Patients with pregnancy or possible pregnancy. 8. Other situation with which medical doctor decide to abort inclusion of the patients.

发起方

agoya University Hospital